Literature DB >> 17289350

Attenuation of UVA-induced damage to human keratinocytes by silymarin.

Alena Svobodová1, Adéla Zdarilová, Jana Malisková, Hana Mikulková, Daniela Walterová, Jitka Vostalová.   

Abstract

BACKGROUND: UV radiation from sunlight is a potent environmental risk factor in skin cancer pathogenesis. UVA is the major portion of UV light reaching the earth surface ( approximately 95%) and it is reported to lead to benign and malignant tumor formation. UVA-mediated cellular damage occurs primarily through the release of reactive oxygen species (ROS) and it is responsible for inflammation, immunosuppression, photoaging and photocarcinogenesis.
OBJECTIVE: The aim of our study was to investigate the potency of silymarin, the polyphenol fraction from the seeds of Silybum marianum, to modulate UVA-induced oxidative damage to human keratinocytes.
METHODS: Skin epidermal cell line HaCaT, extensively used for studying the influence of UV radiation, was chosen as an experimental model. Silymarin's effect on UVA-disrupted cell viability, proliferation, mitochondrial function, and intracellular ATP and GSH level was measured. Furthermore, silymarin's potency to reduce UVA-induced ROS generation, membrane lipid peroxidation, caspase-3 activation and DNA damage was monitored.
RESULTS: Treatment of irradiated HaCaT (20 J/cm(2)) with silymarin (0.7-34 mg/l; 4h) resulted in concentration-dependent diminution of UVA-caused oxidative stress on all studied parameters. Silymarin application extensively reduced GSH depletion and ROS production as well as lipid peroxidation in irradiated cells. Formation of UVA-induced DNA single strand breaks and caspase-3 activity was also significantly decreased by silymarin.
CONCLUSION: The results suggest that silymarin may be beneficial in the treatment of UVA-induced skin oxidative injury and inflammation. However, further studies especially whose using human systems are needed to determine efficacy of silymarin in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17289350     DOI: 10.1016/j.jdermsci.2006.12.009

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  24 in total

1.  Process optimization and photostability of silymarin nanostructured lipid carriers: effect on UV-irradiated rat skin and SK-MEL 2 cell line.

Authors:  Pooja Singh; Mahendra Singh; Jovita Kanoujia; Malti Arya; Shailendra K Saraf; Shubhini A Saraf
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

2.  Silibinin is a potent sensitizer of UVA radiation-induced oxidative stress and apoptosis in human keratinocyte HaCaT cells.

Authors:  Sreekanth Narayanapillai; Chapla Agarwal; Cynthia Tilley; Rajesh Agarwal
Journal:  Photochem Photobiol       Date:  2012-01-10       Impact factor: 3.421

Review 3.  Molecular mechanisms of inhibition of photocarcinogenesis by silymarin, a phytochemical from milk thistle (Silybum marianum L. Gaertn.) (Review).

Authors:  Mudit Vaid; Santosh K Katiyar
Journal:  Int J Oncol       Date:  2010-05       Impact factor: 5.650

Review 4.  Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions.

Authors:  Tomas Koltai; Larry Fliegel
Journal:  J Evid Based Integr Med       Date:  2022 Jan-Dec

5.  Photoprotective properties of new derivatives of kinetin.

Authors:  Vostálová Jitka; Škařupová Denisa; Plíhalová Lucie; Martin Hönig; Zálešák Bohumil; Rajnochová Svobodová Alena
Journal:  Photochem Photobiol Sci       Date:  2022-10-20       Impact factor: 4.328

Review 6.  Multitargeted therapy of cancer by silymarin.

Authors:  Kumaraguruparan Ramasamy; Rajesh Agarwal
Journal:  Cancer Lett       Date:  2008-05-09       Impact factor: 8.679

7.  Inhibition of photocarcinogenesis by platelet-activating factor or serotonin receptor antagonists.

Authors:  Coimbatore S Sreevidya; Noor M Khaskhely; Atsushi Fukunaga; Polina Khaskina; Stephen E Ullrich
Journal:  Cancer Res       Date:  2008-05-15       Impact factor: 12.701

8.  Polydatin, a natural precursor of resveratrol, induces β-defensin production and reduces inflammatory response.

Authors:  Giampietro Ravagnan; Anna De Filippis; Maria Cartenì; Salvatore De Maria; Valentina Cozza; Marcella Petrazzuolo; Maria Antonietta Tufano; Giovanna Donnarumma
Journal:  Inflammation       Date:  2013-02       Impact factor: 4.092

9.  Topical delivery of silymarin constituents via the skin route.

Authors:  Chi-feng Hung; Yin-ku Lin; Li-wen Zhang; Ching-hsien Chang; Jia-you Fang
Journal:  Acta Pharmacol Sin       Date:  2009-12-21       Impact factor: 7.169

10.  The prospective role of plant products in radiotherapy of cancer: a current overview.

Authors:  Banasri Hazra; Subhalakshmi Ghosh; Amit Kumar; B N Pandey
Journal:  Front Pharmacol       Date:  2012-01-09       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.